Systematic evaluation of SARS‐CoV‐2 antigens enables a highly specific and sensitive multiplex serological COVID‐19 assay
Lists
Only you see this
Abstract
These observations demonstrate that a serological test based on a combination of several SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay.
BibTeX
@inproceedings{hober2021systematic,
author = {Sophia Hober and Cecilia Hellström and Jennie Olofsson and Eni Andersson and Sofia Bergström and August Jernbom Falk and Shaghayegh Bayati and Sára Mravinacová and Ronald Sjöberg and Jamil Yousef and Lovisa Skoglund and Sara Kanje and Anna Berling and Anne‐Sophie Svensson and Gabriella Jensen and Henric Enstedt and Delaram Afshari and Lan Xu and Martin Zwahlen and Kalle von Feilitzen and Leo Hanke and Ben Murrell and Gerald M. McInerney and Gunilla B. Karlsson Hedestam and Christofer Lendel and Robert Roth and Ingmar Skoog and Elisabet Svenungsson and Tomas Olsson and Anna Fogdell‐Hahn and Ylva Lindroth and Maria Lundgren and Kimia T. Maleki and Nina Lagerqvist and Jonas Klingström and Rui Da Silva Rodrigues and Sandra Muschiol and Gordana Bogdanović and Laila Sara Arroyo Mühr and Carina Eklund and Camilla Lagheden and Joakim Dillner and Åsa Sivertsson and Sebastian Havervall and Charlotte Thålin and Hanna Tegel and Elisa Pin and Anna Månberg and My Hedhammar and Peter Nilsson},
title = {{Systematic evaluation of SARS‐CoV‐2 antigens enables a highly specific and sensitive multiplex serological COVID‐19 assay}},
booktitle = {Clinical},
year = {2021},
doi = {10.1002/cti2.1312},
}Loading related content...